ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Sanford Health Home To New Stem Cell Clinical Trial – KDLT News

Continue reading

2017-01-05 Michael Zand NEWS

Sublingual versus subcutaneous immunotherapy: patient adherence at a large German allergy center – Dove Medical Press

Sublingual versus subcutaneous immunotherapy: patient adherence at a large German allergy centerDove Medical PressBackground: Many placebo-controlled studies have demonstrated that allergen immunotherapy (AIT) is an effective therapy for treating aller… Continue reading

2017-01-05 Michael Zand NEWS

Medical innovations to watch for in 2017 – CBS News


KDLT News

Sanford Health Home To New Stem Cell Clinical Trial
KDLT News
sanford-stem–cell-trial-1 “As you get over age 45, the tendons aren’t as healthy and as strong as they were when you’re 20, and so over time, with everyday wear and tear, we’ll see small tears occur,” said Hurd. “This time of year we see a lot of …
Stem Cell Therapy Trial at Sanford First of its Kind in US For Shoulder InjuriesBenzinga

all 2 news articles »

Continue reading

2017-01-04 Michael Zand NEWS

CAR-T Immunotherapy Shows Promise in Aggressive Brain Cancers, Case Study Reports – Immuno-Oncology News


CBS News

Medical innovations to watch for in 2017
CBS News
CRISPR. At the top of Agus’ list is a much-discussed gene editing biotechnology called CRISPR, derived from a bacterial protein, that lets scientists clip away or tweak specific portions of DNA. “We saw the rise this year, over and over again, of the …

Continue reading

2017-01-04 Michael Zand NEWS

Scientists learn how to ramp up microbes’ ability to make memories – The Rockefeller University Newswire


Immuno-Oncology News

CAR-T Immunotherapy Shows Promise in Aggressive Brain Cancers, Case Study Reports
Immuno-Oncology News
Immunotherapy using genetically modified immune T-cells (CAR-T) to specifically target the glioma-associated marker IL13Rα2 — a gene expression indicative of an aggressive brain tumor — was reported to be a successful treatment for recurrent …

and more »

Continue reading

2017-01-04 Michael Zand NEWS

Monsanto Licenses CRISPR/Cpf1 From Broad Institute – GenomeWeb


The Rockefeller University Newswire

Scientists learn how to ramp up microbes’ ability to make memories
The Rockefeller University Newswire
“CRISPR, the adaptive immune system found within many bacteria, remembers viruses by storing snippets of their DNA. But in nature, these recording events happen only rarely,” says senior author Luciano Marraffini, head of the Laboratory of Bacteriology.

and more »

Continue reading

2017-01-04 Michael Zand NEWS

Immunotherapy, gene therapy combination shows promise against glioblastoma – Science Daily


I4U News

Monsanto Licenses CRISPR/Cpf1 From Broad Institute
GenomeWeb
NEW YORK (GenomeWeb) – Agricultural giant Monsanto has licensed CRISPR/Cpf1 genome editing technology from the Broad Institute. Under the terms of the agreement, Monsanto gains worldwide, non-exclusive rights to agricultural applications of the …
Monsanto (MON) Enters Global Genome-Editing Licensing Agreement for CRISPR SystemStreetInsider.com
Off-Switch Discovered for CRISPR-Cas9 Gene Editing Tool – I4U NewsI4U News
Altered Genes | The Straight Dope | Salt Lake City | Salt Lake City …Salt Lake City Weekly
Pc-Tablet Media –States Chronicle
all 7 news articles »
Continue reading

2017-01-04 Michael Zand NEWS

Second coming of gene therapy – Bangalore Mirror

Bangalore MirrorSecond coming of gene therapyBangalore MirrorOne of the most important professions in human history has been that of medicine. Disease, illness and malaise are an unfortunate part of life and so it was only natural that any specialist w… Continue reading

2017-01-04 Michael Zand NEWS
  • 1
  • …
  • 2,250
  • 2,251
  • 2,252
  • 2,253
  • 2,254
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Immunotherapy, gene therapy combination shows promise against glioblastoma
Science Daily
“We hope the implementation of our gene therapy strategy for gliomas, used in combination with immune checkpoint blockade, will eventually provide successful treatment for patients with this devastating brain cancer,” says Maria Castro, Ph.D., co …

and more »